SCHEMBL6646173

SCHEMBL6646173

S=C1Nc2ccccc2C2CCCC12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.42
SRC P12931 3/20 0.40
HTR5A P47898 1/20 0.39
NOS1 P29475 3/20 0.39
NOS3 P29474 1/20 0.39
NOS2 P35228 1/20 0.39
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TSHR P16473 2/20 0.35
AURKA O14965 1/20 0.35
AURKB Q96GD4 1/20 0.35
LMNA P02545 1/20 0.34
PARP1 P09874 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
HK1 P19367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6645884 0.96 EGFR (0.42) EGFRSRCHTR5ANOS1NOS3
SCHEMBL4763337 0.78 IDO1 (0.45) HTR5ANOS1NOS3NOS2ALDH1A1
SCHEMBL6137734 0.78 IDO1 (0.45) HTR5ANOS1NOS3NOS2ALDH1A1
SCHEMBL4761869 0.78 IDO1 (0.45) HTR5ANOS1NOS3NOS2ALDH1A1
SCHEMBL6642318 0.76 NOS3 (0.44) NOS1NOS3NOS2MEN1KMT2A
SCHEMBL6639911 0.76 NOS3 (0.45) NOS1NOS3NOS2MEN1KMT2A
SCHEMBL6642314 0.76 NOS3 (0.44) HTR5ANOS1NOS3NOS2MEN1
SCHEMBL6642761 0.76 NOS3 (0.44) HTR5ANOS1NOS3NOS2ALDH1A1
SCHEMBL6642389 0.76 NOS3 (0.44) HTR5ANOS1NOS3NOS2MEN1
SCHEMBL7252422 0.74 IDO1 (0.45) NOS1ALDH1A1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054869-B1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AG (DE) 2004-09-22 EP disclosed
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 US disclosed
EP-1054869-A1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-11-29 EP disclosed
WO-1999041240-A1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1999-08-19 WO disclosed